Patients with life threatening disease being denied treatment under Rashtriya Aarogya Nidhi, Ayushman Bharat: HC asks AIIMS to reply

Published On 2019-12-19 07:42 GMT   |   Update On 2019-12-19 07:42 GMT
The plea said as per rules, those who are covered under Ayushman Bharat - Pradhan Mantri Jan Arogya Yojna cannot avail the benefits of RAN scheme.

New Delhi: The Delhi High Court on Tuesday sought response of the Centre and AIIMS on a plea claiming lacunae in two major health related schemes -- Rashtriya Aarogya Nidhi and Ayushman Bharat -- due to which patients suffering from life threatening diseases are being deprived of monetary benefits to avail treatment.


Justice Navin Chawla issued notices to the Ministry of Health and Family Services, Directorate General of Health Services and All India Institute of Medical Sciences (AIIMS) on a petition filed by a minor, who is suffering from severe aplastic anaemia and requires bone marrow transplant which is the only life saving treatment for the disease.


The court asked the authorities to file their responses on the plea and listed the matter for further hearing on January 16.


In the petition filed through his mother, the 11-year-old boy, a resident of Bihar, has sought the court's direction to the AIIMS to treat him with bone marrow transplantation which would cost around Rs 12 lakh.


Advocate Gaurav Kumar Bansal, appearing for the minor, has also sought direction to the Health Ministry to remove the lacunae which debars persons like the petitioner, suffering from deadly diseases involving transplant treatment, to avail benefits as provided under the Rashtriya Aarogya Nidhi (RAN) scheme.


The plea said as per rules, those who are covered under Ayushman Bharat - Pradhan Mantri Jan Arogya Yojna cannot avail the benefits of RAN scheme.


Neither bone marrow transplant is covered under Ayushman Bharat scheme nor rules allow the petitioner to avail benefits of RAN scheme, due to which the child has been left with no option except to die, it alleged.


It sought to declare that both the schemes, RAN and Ayushman Bharat, compliment each other to help patients like the petitioner.


The plea said the court had brought in RAN scheme to provide financial assistance for medical treatments to patients belonging to the below poverty line (BPL) category, who are suffering from life threatening diseases relating to the heart, kidney and liver, at government hospitals and super speciality facilities.


Under RAN scheme, the patient was eligible for maximum financial assistance of Rs 15 lakh.


Thereafter, the government launched Ayushman Bharat - Pradhan Mantri Jan Arogya Yojna, which covers the poor and economically backward segment and gives insurance cover of Rs five lakh per family.


Read Also: Health Minister updates on 75 medical colleges, 22 AIIMS developing under PMSSY


The plea said Ayushman Bharat scheme does not cover diseases which need transplant, i.e, end stage renal disease, chronic kidney and liver disease, aplastic anaemia and cancer.


"However, at the same time RAN scheme, whose object is to provide one time financial assistance to poor patients living below threshold poverty line and suffering from life threatening diseases relating to heart, kidney and liver..., is also denying financial assistance only because of superficial reason that family of the patient is covered under the Ayushman Bharat scheme," it said.


Read Also: FIRST: AIIMS, ICMR working on Virtual Autopsy technique

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News